Show simple item record

dc.contributor.authorMatorras Weinig, José Roberto
dc.contributor.authorPérez Sanz, Jairo
dc.contributor.authorCorcóstegui, Beatriz
dc.contributor.authorPérez Ruiz, Irantzu
dc.contributor.authorMalaina Celada, Iker ORCID
dc.contributor.authorQuevedo, Sara María
dc.contributor.authorAspichueta Vivanco, Fermín
dc.contributor.authorCrisol, Lorena
dc.contributor.authorMartinez Indart, Lorea
dc.contributor.authorPrieto Molano, María Begoña
dc.contributor.authorExpósito Navarro, María Antonia
dc.date.accessioned2021-08-06T12:08:28Z
dc.date.available2021-08-06T12:08:28Z
dc.date.issued2020-12
dc.identifier.citationF&S reports 1(3) : 219-226 (2020)es_ES
dc.identifier.issn2666-3341
dc.identifier.urihttp://hdl.handle.net/10810/52756
dc.description.abstractObjective: To evaluate the influence on sperm parameters and invitro fertilization (IVF) outcomes of the administration of 400 mg/day of vitamin E for 3 months to men from infertile couples who are undergoing IVF. Design: Double-blind, placebo-controlled, randomized study. Setting: Human reproduction unit of a university hospital. Patients: A total of 101 couples, 50 in the vitamin E group and 51 in the placebo group, undergoing IVF, among whom 64.4% of cases had an abnormal spermiogram according to World Health Organization (WHO) criteria. Interventions: Vitamin E (alpha-tocopherol), 400 mg daily by mouth for 3 months, with sperm analysis performed immediately before starting the treatment and 3 months later on the day of IVF. Main Outcome Measures: WHO sperm parameters and IVF outcomes. Results: Although there was a statistically significant increase in progressive motility in the vitamin E group compared with before-treatment values, a similar increase occurred in the placebo group. Normal morphology was even better in the placebo group. Regarding IVF outcomes, better fertilization rates were observed in the placebo group, but the live-birth rate per transfer was statistically significantly higher in the vitamin E group: 17 (41.46%) of 41 versus 9 (20.46%) of 44 in the placebo group. Although the clinical pregnancy rates (both per transfer and per cycle started) and the implantation rate were somewhat higher in the vitamin E group (43.9% and 25%; 36.0% and 22.0%; and 24.7% and 14.1%, respectively), the increase was not statistically significant. Conclusions: The effect of vitamin E on classic sperm parameters was not an improvement over placebo. Nonetheless, vitamin E administration was associated with a statistically significantly higher live-birth rate, and there was a trend toward better results in other IVF parameters.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectfertilization ratees_ES
dc.subjectROSes_ES
dc.subjectpregnancyes_ES
dc.subjectratesperm parameterses_ES
dc.subjectvitamin Ees_ES
dc.titleEffect of vitamin E administered to men in infertile couples on sperm and assisted reproduction outcomes: a double-blind randomized studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder2020 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)es_ES
dc.rights.holderAtribución-NoComercial-SinDerivadas 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2666334120300775?via%3Dihubes_ES
dc.identifier.doi10.1016/j.xfre.2020.09.006
dc.departamentoesEspecialidades médico-quirúrgicases_ES
dc.departamentoesMatemática Aplicada, Estadística e Investigación Operativaes_ES
dc.departamentoeuMatematikaren eta zientzia esperimentalen didaktikaes_ES
dc.departamentoeuMedikuntza eta kirurgia espezialitateakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

2020 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Except where otherwise noted, this item's license is described as 2020 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)